Literature DB >> 2749290

Case report 517. Mesenchymal chondrosarcoma of the femur.

F Bertoni1, P Bacchini, P Picci, F Gherlinzoni.   

Abstract

Entities:  

Mesh:

Year:  1989        PMID: 2749290     DOI: 10.1007/bf00360974

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  6 in total

1.  Osteosarcoma with small cells simulating Ewing's tumor.

Authors:  F H Sim; K K Unni; J W Beabout; D C Dahlin
Journal:  J Bone Joint Surg Am       Date:  1979-03       Impact factor: 5.284

2.  Mesenchymal chondrosarcoma. A clinicopathologic analysis of 35 patients with emphasis on treatment.

Authors:  A G Huvos; G Rosen; M Dabska; R C Marcove
Journal:  Cancer       Date:  1983-04-01       Impact factor: 6.860

3.  Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.

Authors:  G Rosen; B Caparros; A G Huvos; C Kosloff; A Nirenberg; A Cacavio; R C Marcove; J M Lane; B Mehta; C Urban
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

4.  Mesenchymal chondrosarcoma of bone and soft tissues.

Authors:  F Bertoni; P Picci; P Bacchini; R Capanna; V Innao; G Bacci; M Campanacci
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

5.  Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases.

Authors:  Y Nakashima; K K Unni; T C Shives; R G Swee; D C Dahlin
Journal:  Cancer       Date:  1986-06-15       Impact factor: 6.860

6.  Ewing's sarcoma: ten-year experience with adjuvant chemotherapy.

Authors:  G Rosen; B Caparros; A Nirenberg; R C Marcove; A G Huvos; C Kosloff; J Lane; M L Murphy
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860

  6 in total
  1 in total

1.  Case report 788: Mesenchymal chondrosarcoma of the soft tissue of the left foot.

Authors:  C P Adler
Journal:  Skeletal Radiol       Date:  1993       Impact factor: 2.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.